Viewing Study NCT06682156


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-02-25 @ 6:30 PM
Study NCT ID: NCT06682156
Status: RECRUITING
Last Update Posted: 2024-11-12
First Post: 2024-11-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Newly Diagnosed Multiple Myeloma View
Keywords: